Upgrade to FINVIZ*Elite to get real-time quotes, intraday charts, and advanced charting tools.

NEW: Fundamental data now powered by FactSet with hourly updates!

PRME | Prime Medicine Inc

Index	RUT	P/E	-	EPS (ttm)	-1.70	Insider Own	64.70%	Shs Outstand	97.21M	Perf Week	-7.31%
Market Cap	1.07B	Forward P/E	-	EPS next Y	-1.79	Insider Trans	-2.21%	Shs Float	33.45M	Perf Month	-13.29%
Income	-158.09M	PEG	-	EPS next Q	-0.46	Inst Own	24.96%	Short Float / Ratio	15.22% / 13.14	Perf Quarter	-24.66%
Sales	0.00M	P/S	-	EPS this Y	56.61%	Inst Trans	-	Short Interest	5.09M	Perf Half Y	-1.61%
Book/sh	2.47	P/B	4.47	EPS next Y	1.64%	ROA	-56.93%	Target Price	22.67	Perf Year	-
Cash/sh	2.13	P/C	5.17	EPS next 5Y	-	ROE	-68.24%	52W Range	11.03 - 21.73	Perf YTD	-40.64%
Dividend	-	P/FCF	-	EPS past 5Y	-	ROI	-62.73%	52W High	-49.24%	Beta	-
Dividend %	-	Quick Ratio	7.61	Sales past 5Y	-33.33%	Gross Margin	-	52W Low	0.00%	ATR	0.67
Employees	175	Current Ratio	7.61	Sales Q/Q	-	Oper. Margin	0.00%	RSI (14)	35.55	Volatility	5.34% 5.51%
Optionable	Yes	Debt/Eq	0.11	EPS Q/Q	-25.84%	Profit Margin	-	Rel Volume	0.38	Prev Close	11.08
Shortable	Yes	LT Debt/Eq	0.05	Earnings	Aug 07 AMC	Payout	-	Avg Volume	387.43K	Price	11.03
Recom	1.67	SMA20	-10.79%	SMA50	-15.49%	SMA200	-25.37%	Volume	75,493	Change	-0.45%

Date	Action	Analyst	Rating Change	Price Target Change
Jul-31-23	Initiated	Guggenheim	Buy	$24
Apr-18-23	Initiated	Stifel	Buy	$18
Nov-14-22	Initiated	Morgan Stanley	Equal-Weight	$23
Nov-14-22	Initiated	JP Morgan	Overweight	$27
Nov-14-22	Initiated	Jefferies	Buy	$25
Nov-14-22	Initiated	Goldman	Neutral	$22

Sep-19-23 08:00AM	Prime Medicine to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-31-23 08:00AM	Prime Medicine to Present at Upcoming Investor Conferences (GlobeNewswire)
Aug-07-23 04:01PM	Prime Medicine Reports Second Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -8.66%
Jul-25-23 07:45AM	2 Cathie Wood Stocks That Could Be Hidden Gems (Motley Fool)
Jun-29-23 08:46AM	We're Hopeful That Prime Medicine (NASDAQ:PRME) Will Use Its Cash Wisely (Simply Wall St.)
08:00AM	Loading…
Jun-22-23 08:00AM	Prime Medicine and Cimeio Therapeutics Announce Research Collaboration to Develop Prime Edited Shielded-Cell & Immunotherapy Pairs for Genetic Diseases, Acute Myeloid Leukemia and Myelodysplastic Syndrome (GlobeNewswire)
Jun-02-23 10:15AM	Cathie Wood Goes Bargain-Hunting: 3 Stocks She Just Bought (Motley Fool) +9.15%
May-31-23 08:00AM	Prime Medicine to Present at Investor Conferences in June (GlobeNewswire)
May-26-23 09:45AM	Cathie Wood Goes Bargain Hunting: 3 Stocks She Just Bought (Motley Fool)
May-17-23 04:05PM	Prime Medicine to Present at Virtual Investor Conferences in May (GlobeNewswire)
06:00AM	Prime Medicine to Present New Preclinical Data Highlighting Broad Potential of Prime Editing Technology at ASGCT 26th Annual Meeting (GlobeNewswire)
May-11-23 08:00AM	Prime Medicine Reports First Quarter 2023 Financial Results and Provides Business Updates (GlobeNewswire) -10.61%
Mar-27-23 08:00AM	Prime Medicine to Present at Guggenheim Healthcare Talks Genomic Medicines and Rare Disease Days (GlobeNewswire) +5.89%
Mar-09-23 08:00AM	Prime Medicine Reports Fourth Quarter and Full Year 2022 Financial Results and Provides Business Update (GlobeNewswire)
Feb-27-23 08:00AM	Prime Medicine to Present at Cowen 43rd Annual Health Care Conference (GlobeNewswire)
05:56AM	Loading…
Jan-20-23 05:56AM	We Think Prime Medicine (NASDAQ:PRME) Needs To Drive Business Growth Carefully (Simply Wall St.)
Jan-09-23 07:00AM	Prime Medicine Announces Recent Progress and Highlights 2023 Strategic Priorities (GlobeNewswire)
Jan-03-23 08:00AM	Prime Medicine to Present at 41st Annual J.P. Morgan Healthcare Conference (GlobeNewswire) -5.60%
Nov-01-22 04:13PM	After Prime Medicine, What's the Next Gene Editing IPO? (TheStreet.com) +12.22%
Oct-24-22 05:30PM	Prime Medicine Announces Closing of Upsized Initial Public Offering (GlobeNewswire)
Oct-20-22 12:45PM	UPDATE 1-Biotech firm Prime Medicine valued at $1.8 bln in strong debut (Reuters)
Oct-19-22 09:47PM	Prime Medicine Announces Pricing of Upsized Initial Public Offering (Business Wire)

Prime Medicine, Inc. is a biotechnology company, which engages in developing one-time curative genetic therapies. The company was founded by David R. Liu on September 13, 2019 and is headquartered in Cambridge, MA.

Insider Trading	Relationship	Date	Transaction	Cost	#Shares	Value ($)	#Shares Total	SEC Form 4
GV 2019 GP, L.L.C.	10% Owner	Jun 21	Sale	14.97	19,003	284,496	0	Jun 22 05:03 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 20	Sale	15.06	37,405	563,248	0	Jun 22 05:03 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 16	Sale	15.02	6,532	98,109	0	Jun 20 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 15	Sale	14.92	66,659	994,326	0	Jun 20 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 14	Sale	14.87	28,960	430,684	0	Jun 15 04:22 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 13	Sale	15.13	28,100	425,102	0	Jun 15 04:22 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 12	Sale	14.98	16,031	240,151	0	Jun 13 04:20 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 09	Sale	14.48	15,672	226,984	0	Jun 13 04:20 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 08	Sale	15.74	5,000	78,686	0	Jun 09 04:24 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 07	Sale	16.92	15,000	253,871	0	Jun 09 04:24 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 06	Sale	17.02	29,975	510,166	0	Jun 07 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 05	Sale	16.70	22,434	374,612	0	Jun 07 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Jun 01	Sale	14.36	45,223	649,194	0	Jun 02 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 31	Sale	13.65	16,633	227,004	0	Jun 02 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 30	Sale	13.70	16,805	230,240	0	May 31 04:15 PM
GV 2019 GP, L.L.C.	10% Owner	May 26	Sale	13.70	12,602	172,603	0	May 31 04:15 PM
GV 2019 GP, L.L.C.	10% Owner	May 25	Sale	13.38	23,161	309,973	0	May 26 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 24	Sale	13.66	7,900	107,920	0	May 26 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 23	Sale	14.74	43,939	647,648	0	May 24 05:07 PM
GV 2019 GP, L.L.C.	10% Owner	May 22	Sale	14.13	87,922	1,242,092	0	May 24 05:07 PM
GV 2019 GP, L.L.C.	10% Owner	May 19	Sale	13.88	63,212	877,066	0	May 22 04:21 PM
GV 2019 GP, L.L.C.	10% Owner	May 18	Sale	13.04	27,098	353,271	0	May 22 04:21 PM
GV 2019 GP, L.L.C.	10% Owner	May 17	Sale	12.77	15,000	191,600	10,735,324	May 18 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 16	Sale	12.59	50,649	637,676	10,750,324	May 18 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 15	Sale	12.74	157,952	2,012,087	10,800,973	May 16 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 12	Sale	12.72	27,290	347,222	10,958,925	May 16 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 11	Sale	13.13	26,626	349,533	10,986,215	May 12 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 10	Sale	14.03	87,397	1,225,804	11,012,841	May 12 04:16 PM
GV 2019 GP, L.L.C.	10% Owner	May 09	Sale	14.08	321,238	4,522,613	11,100,238	May 10 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	May 08	Sale	14.13	100,772	1,423,727	11,421,476	May 10 04:17 PM
GV 2019 GP, L.L.C.	10% Owner	Oct 24	Buy	17.00	800,000	13,600,000	11,522,248	Oct 26 08:02 PM
NELSEN ROBERT	Director	Oct 24	Buy	17.00	800,000	13,600,000	6,128,297	Oct 26 08:01 PM
ARCH Venture Partners X, LLC	10% Owner	Oct 24	Buy	17.00	800,000	13,600,000	6,128,297	Oct 26 08:01 PM
Cahill Thomas	Director	Oct 24	Buy	17.00	400,000	6,800,000	5,305,679	Oct 26 08:00 PM

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

PRME | Prime Medicine Inc

Upgrade your FINVIZ experience